Telemedicine Education for Type 1 Diabetes
(TREAT-ED Trial)
Trial Summary
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on education and support rather than medication changes.
What data supports the effectiveness of the treatment TREAT-ED Virtual Group Diabetes Self-Management Education and Support for type 1 diabetes?
Research shows that telemedicine, which involves using technology to provide healthcare remotely, can help people with type 1 diabetes manage their condition better. For example, studies have found that telemedicine can improve blood sugar control and provide effective diabetes education, especially in young adults and children.12345
Is telemedicine education for type 1 diabetes generally safe for humans?
Research on telemedicine interventions for type 1 diabetes, including a study on adults using insulin pumps, has shown that these methods are safe over a 12-month period. Additionally, a telemedicine protocol during the COVID-19 pandemic helped reduce acute complications in high-risk patients, suggesting it is a safe approach for managing diabetes.36789
How is the TREAT-ED Virtual Group Diabetes Self-Management Education and Support treatment different from other treatments for type 1 diabetes?
The TREAT-ED Virtual Group Diabetes Self-Management Education and Support treatment is unique because it uses telemedicine to provide group education and support, making it accessible to people in rural or underserved areas. This approach focuses on increasing knowledge, skills, and confidence in managing diabetes through remote, person-centered interventions led by a team of diabetes care experts.310111213
What is the purpose of this trial?
Emerging adults with type 1 diabetes are a vulnerable population. While diabetes self-management and education is known to offer opportunities to develop self-management skills required to achieve and maintain short- and long-term diabetes outcomes, emerging adults are reported to have poor clinic attendance and in turn low participation in diabetes self-management education and support services. This pilot study aims to test a novel approach to diabetes self-management education and support that incorporates technological and applied learning-driven methods delivered through group telemedicine visits to improve emerging adults engagement in diabetes self-management education and support with the ultimate goal of improving diabetes outcomes.
Research Team
Ingrid Libman, MD
Principal Investigator
University of Pittsburgh
Linda Siminerio, RN, PhD, CDCES
Principal Investigator
University of Pittsburgh
Eligibility Criteria
This trial is for emerging adults with Type 1 Diabetes who may struggle to attend clinic appointments. It's designed to help them learn and manage their diabetes better using group telemedicine sessions.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in diabetes self-management education and support through group telemedicine sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- TREAT-ED Virtual Group Diabetes Self-Management Education and Support
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pittsburgh
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator